Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing-February 2024-www.financetom.com

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing

Oct 23, 2024 12:45 AM

03:19 AM EDT, 10/23/2024 (MT Newswires) -- David Zaccardelli, Director, President and Chief Executive Officer, on October 18, 2024, sold 514,152 shares in Verona Pharma ( VRNA ) for $2,253,237. Following the Form 4 filing with the SEC, Zaccardelli has control over a total of 14,736,552 shares of the company, with 14,736,552 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1657312/000110465924110659/xslF345X05/tm2426639-2_4seq1.xml

Price: 34.97, Change: +0.10, Percent Change: +0.29

Previous page： Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon Next page： SECURITIES CLASS ACTION NOTICE: Girard Sharp Law Firm Encourages Current and Former 3M Company Shareholders Who Received Neogen Corporation Shares in Connection With Neogen Corporation’s Acquisition o

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

Sep 22, 2025

Issues Open Letter to Shareholders Outlining Its Belief that the Proposed Merger Materially Undervalues STAAR Contends that STAAR’s Board Failed In Its Responsibilities by Not Running a Thorough Process and Relying on Undue Skepticism about the Company’s Prospects Shareholders Deserve Fair Value for the Company HONG KONG--(BUSINESS WIRE)-- Yunqi Capital Limited (together with its affiliates and the funds it...

SECURITIES CLASS ACTION NOTICE: Girard Sharp Law Firm Encourages Current and Former 3M Company Shareholders Who Received Neogen Corporation Shares in Connection With Neogen Corporation’s Acquisition o

Sep 22, 2025

SAN FRANCISCO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action law firm, has filed a securities class action against Neogen Corporation ( NEOG ) (“Neogen”). According to the complaint, the class includes “all current and former 3M shareholders who received NEOG common stock in exchange for Garden SpinCo shares pursuant to...

Form 8.3 - UNITE Group PLC/The

Sep 22, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

Lion Equity Partners Completes Acquisition of Custom Tube Products, Inc.

Sep 22, 2025

DENVER--(BUSINESS WIRE)-- Lion Equity Partners, a Denver-based private equity firm specializing in corporate carve-outs, acquired Custom Tube Products (“Custom Tube Products” or “CTP”), an Edgewater, Florida-based manufacturer of metal tubing assemblies and components. Custom Tube Products is a leading manufacturer of precision metal tubing assemblies and components serving the aerospace, medical, and industrial markets. Custom Tube will partner with Lion...